These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6873999)

  • 21. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
    McDonald TL; Donnelly T; Weber A; Quenette L
    Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection.
    Takei I; Asaba Y; Kasatani T; Maruyama T; Watanabe K; Yanagawa T; Saruta T; Ishii T
    J Autoimmun; 1992 Dec; 5(6):665-73. PubMed ID: 1489482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
    Morimoto M; Ohji T; Iwata H; Hayashi T
    Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus.
    Henderson DC; Tosta CE; Wedderburn N
    Clin Exp Immunol; 1978 Aug; 33(2):357-9. PubMed ID: 719954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
    Weiland E; Weiland F; Grossmann A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate resistance to Listeria monocytogenes in tumor-bearing mice.
    Gahan CG; Barrett JR; O'Brien MG; O'Sullivan GC; Shanahan F; Collins JK
    J Leukoc Biol; 1997 Dec; 62(6):726-32. PubMed ID: 9400813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trojan Horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection.
    Cafruny WA; Bradley SE
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3005-12. PubMed ID: 9000091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice.
    Monteyne P; Coutelier JP
    J Gen Virol; 1994 May; 75 ( Pt 5)():1173-6. PubMed ID: 8176379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of extracts obtained by high efficiency gel chromatography of lactic dehydrogenase virus infected mouse serum and cytosol from human tumors using leukocyte adherence inhibition assay.
    Jandová A; Mejsnarová B; Motycka K; Coupek J; Sanitrák J; Heyberger K; Pezlarová J
    Neoplasma; 1979; 26(3):261-6. PubMed ID: 394008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus.
    Inada T; Mims CA
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmented nonspecific resistance and simultaneous impairment of specific immunity to Listeria monocytogenes in tumor-bearing mice.
    Nomoto K; Mitsuyama M; Miake S; Yokokura T; Nomoto K
    J Clin Lab Immunol; 1987 Oct; 24(2):75-9. PubMed ID: 3501807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection.
    Even C; Rowland RR; Plagemann PG
    J Virol; 1995 Sep; 69(9):5666-76. PubMed ID: 7637013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactic dehydrogenase virus alteration of lymphocyte circulation.
    Mongini PK; Rosenberg LT
    J Immunol; 1978 Feb; 120(2):459-62. PubMed ID: 621389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication.
    Ritzi DM; Holth M; Smith MS; Swart WJ; Cafruny WA; Plagemann GW; Stueckemann JA
    J Gen Virol; 1982 Apr; 59(Pt 2):245-62. PubMed ID: 7077301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of lymphocyte trapping by a passenger virus in murine ascitic tumors: characterization of lactic dehydrogenase virus (LDV) as the inhibitory component and analysis of the mechanism of inhibition.
    Mongini PK; Rosenberg LT
    J Exp Med; 1976 Jan; 143(1):100-13. PubMed ID: 1244415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
    Harty JT; Chan SP; Contag CH; Plagemann PG
    J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
    McDonald TL
    Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages.
    Lussenhop N; Holmes B; Cafruny WA; Plagemann PG
    J Gen Virol; 1982 Jul; 61 (Pt l)():25-32. PubMed ID: 7119750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages.
    Isakov N; Feldman M; Segal S
    Cell Immunol; 1982 Jan; 66(2):317-32. PubMed ID: 6461420
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages.
    Cafruny WA; Jones QA; Haven TR; Zitterkopf NL; Plagemann PG; Rowland RR
    Virus Res; 2003 Mar; 92(1):83-7. PubMed ID: 12606079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.